Veru Inc Sustainability Reports
Veru Inc. is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic and inflammatory diseases, with programs including enobosarm and sabizabulin.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900ER63TFLEIJV631
8 reports from 2015 to 2023
Company Profile
Veru Inc. is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic and inflammatory diseases, with programs including enobosarm and sabizabulin.
Reports
8 total
Limited sustainability disclosure available
The reports currently shown are annual reports without dedicated sustainability sections.
